Sun Pharm Industries Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM INDUSTRIES, and when can generic versions of SUN PHARM INDUSTRIES drugs launch?
SUN PHARM INDUSTRIES has one hundred and sixty-seven approved drugs.
There is one US patent protecting SUN PHARM INDUSTRIES drugs. There are two tentative approvals on SUN PHARM INDUSTRIES drugs.
There are twenty-two patent family members on SUN PHARM INDUSTRIES drugs in eighteen countries and one hundred and twenty-four supplementary protection certificates in sixteen countries.
Summary for Sun Pharm Industries
International Patents: | 22 |
US Patents: | 1 |
Tradenames: | 100 |
Ingredients: | 97 |
NDAs: | 167 |
Drugs and US Patents for Sun Pharm Industries
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Industries | DISOPYRAMIDE PHOSPHATE | disopyramide phosphate | CAPSULE;ORAL | 070351-001 | Dec 17, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm Industries | TRIMETHOBENZAMIDE HYDROCHLORIDE | trimethobenzamide hydrochloride | CAPSULE;ORAL | 076570-001 | Aug 28, 2003 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Industries | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 075896-003 | Nov 2, 2004 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Industries | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 073582-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm Industries
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
Sun Pharm Industries | BACTRIM DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
Sun Pharm Industries | BACTRIM PEDIATRIC | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Sun Pharm Industries Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 6385938 | ⤷ Try a Trial |
South Africa | 201502692 | ⤷ Try a Trial |
South Korea | 20150069005 | ⤷ Try a Trial |
China | 104884043 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Industries Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0443983 | C00443983/03 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
0678503 | C300499 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE OMVATTEND ALISKIREN OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110114 |
1261586 | 12C0028 | France | ⤷ Try a Trial | PRODUCT NAME: ASSOCIATION COMPRENANT LA SAXAGLIPTINE OU UN DE SES SELS ET LA METFORMINE OU UN DE SES SELS, Y COMPRIS L'ASSOCIATION CHLORHYDRATE DE SAXAGLIPTINE ET CHLORHYDRATE DE METFORMINE; REGISTRATION NO/DATE: EU/1/11/731/001 20111124 |
1730131 | C01730131/02 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: EMPAGLIFLOZIN UND METFORMINHYDROCHLORID; REGISTRATION NO/DATE: SWISSMEDIC 65570 12.11.2015 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.